Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents

Author(s): Malihe Akhavan, Naser Foroughifar*, Hoda Pasdar, Ahmadreza Bekhradnia

Journal Name: Combinatorial Chemistry & High Throughput Screening
Accelerated Technologies for Biotechnology, Bioassays, Medicinal Chemistry and Natural Products Research

Volume 22 , Issue 10 , 2019

Become EABM
Become Reviewer

Abstract:

Aims and Objective: The magic scaffolds rhodanine and thiazolidine are very important heterocyclic compounds in drug design and discovery. Those are important heterocyclic compounds that have attracted a great deal of attention due to the fact that they exhibit a variety of bioactivities including antibacterial, antifungal, antiviral, antimalarial, and anti-inflammatory activities. These agents often exhibit selective toxicity. The goal of this study was molecular docking, green and solvent-free efficient synthesis of a new series of hetero/aromatic substituted rhodanine and thiazolidine analogues and then investigation of their antimicrobial activity.

Materials and Methods: To a mixture of TZD or rhodanine (1 mmol) in the presence of ionic liquid ChCl/urea, various aldehyde (1 mmol) was added. After completion of the reaction, obtained crude compound was collected by filtration and products were recrystallized from ethanol. The binding-free energy between all synthesized compounds with 3EEJ protein (C. glabrata enzyme) were obtained by molecular docking studies. These compounds were evaluated using microdilution method against (ATCC 6538) and (ATCC 12228) Gram-negative, (ATCC 8739) and (ATCC 9027) as Gram-positive and (ATCC 1012), (ATCC 339), C. (ATCC 1057), (ATCC 503), (ATCC 340) and (ATCC 194) as fungi.

Results: All of the acceptable products were determined by 1H NMR, 13C NMR, Mas and FT-IR spectroscopy. The binding-free energy between compounds 10a and 10b with 3EEJ protein were found to be -8.08 kcal/mol and -8.15 kcal/mol, respectively. These compounds having a heteroaromatic ring attached to the TZD or rhodanine core showed excellent antimicrobial activity with MIC values of 0.25-8 μg/mL (compound 10a) and 0.5-16 μg/mL (compound 10b) against the most tested fungi strains, Gram-positive and Gram-negative bacteria.

Conclusion: A convenient and rapid method has been developed for the synthesis of rhodanine and thiazolidine-2,4-dione (TZD) derivatives as efficient antimicrobial agents using a Deep Eutectic Ionic Liquids (DEILs) choline chloride urea under solvent-free condition. Among the newly synthesized compounds, (Z)-5-((quinoxalin-3-yl) methylene) thiazolidine-2, 4-dione (10a) and (Z)- 5- ((quinoxalin-3-yl) methylene)-2-thioxothiazolidin-one (10b) exerted the promising effect and these compounds can be considered to be further probed as inhibitors of cgDHFR enzyme.

Keywords: Solvent-free conditions, Deep Eutectic Solvents (DESs), antimicrobial activity, molecular docking studies, rhodanine, thiazolidine.

[1]
Pejchalová, M.; Havelek, R.; Královec, K.; Růžičková, Z.; Pejchal, V. Novel derivatives of substituted 6-fluorobenzothiazole diamides: synthesis, antifungal activity and cytotoxicity. Med. Chem. Res., 2017, 26(9), 1847-1862.
[http://dx.doi.org/10.1007/s00044-017-1894-x]
[2]
(a)Vessally, E.; Edjlali, L.; Hosseinian, A.; Bekhradnia, A.; Esrafili, M.D. Novel routes to quinoline derivatives from Npropargylamines. RSC Advances, 2016, 6(55), 49730-49746.
[http://dx.doi.org/10.1039/C6RA05221E]
(b)Vessally, E.; Hosseinian, A.; Edjlali, L.; Bekhradnia, A.; Esrafili, M.D. New page to access pyrazines and their ring fused analogues: synthesis from N-propargylamines. Curr. Org. Synth., 2017, 14(4), 557-567.
[http://dx.doi.org/10.2174/1570179413666160818144816]
[3]
Ediriweera, M.K.; Tennekoon, K.H.; Samarakoon, S.R. A review on ethnopharmacological applications, pharmacological activities, and bioactive compounds of Mangifera indica (Mango). Evid. Based Complement. Alternat. Med., 2017, 20176949835
[http://dx.doi.org/10.1155/2017/6949835] [PMCID: PMC5804368]
[4]
Shafiee, A.; Kassaee, M.Z.; Bekhradnia, A.R. Synthesis of novel 3, 4‐diaryl‐1H‐pyrroles. J. Heterocycl. Chem., 2007, 44(2), 471-474.
[http://dx.doi.org/10.1002/jhet.5570440232]
[5]
Zhang, Z-H.; Chen, Y.; Yan, X-J.; Sun, Y.; Yang, X-M.; Cai, X-Y.; You, S. Synthesis and evaluation of novel urea and amide derivatives of 2-amino-4-phenylthiazole as potential antibacterial agents. Med. Chem. Res., 2017, 26(9), 2080-2087.
[http://dx.doi.org/10.1007/s00044-017-1910-1]
[6]
Sudo, K.; Matsumoto, Y.; Matsushima, M.; Fujiwara, M.; Konno, K.; Shimotohno, K.; Shigeta, S.; Yokota, T. Novel hepatitis C virus protease inhibitors: thiazolidine derivatives. Biochem. Biophys. Res. Commun., 1997, 238(2), 643-647.
[http://dx.doi.org/10.1006/bbrc.1997.7358] [PMID: 9299567]
[7]
Frlan, R.; Kovač, A.; Blanot, D.; Gobec, S.; Pečar, S.; Obreza, A. Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of MurC and MurD as potential antibacterial agents. Molecules, 2008, 13(1), 11-30.
[http://dx.doi.org/10.3390/molecules13010011] [PMID: 18259126]
[8]
Cuenca-Estrella, M.; Gomez-Lopez, A.; Alastruey-Izquierdo, A.; Bernal-Martinez, L.; Cuesta, I.; Buitrago, M.J.; Rodriguez-Tudela, J.L. Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. J. Clin. Microbiol., 2010, 48(5), 1782-1786.
[http://dx.doi.org/10.1128/JCM.02316-09] [PMID: 20220169]
[9]
Azizi, N.; Marimi, M. Fast 62-92% yield preparation of amino acid dithiocarbamates in green solvent at room temperature. Environ. Chem. Lett., 2013, 11(4), 371-376.
[http://dx.doi.org/10.1007/s10311-013-0417-3]
[10]
Liu, Y-T.; Chen, Y-A.; Xing, Y-J. Synthesis and characterization of novel ternary deep eutectic solvents. Chin. Chem. Lett., 2014, 25(1), 104-106.
[http://dx.doi.org/10.1016/j.cclet.2013.09.004]
[11]
Yue, D.; Jia, Y.; Yao, Y.; Sun, J.; Jing, Y. Structure and electrochemical behavior of ionic liquid analogue based on choline chloride and urea. Electrochim. Acta, 2012, 65, 30-36.
[http://dx.doi.org/10.1016/j.electacta.2012.01.003]
[12]
Stefanovic, R.; Ludwig, M.; Webber, G.B.; Atkin, R.; Page, A.J. Nanostructure, hydrogen bonding and rheology in choline chloride deep eutectic solvents as a function of the hydrogen bond donor. Phys. Chem. Chem. Phys., 2017, 19(4), 3297-3306.
[http://dx.doi.org/10.1039/C6CP07932F] [PMID: 28085165]
[13]
Pansare, D.N.; Shinde, D.B. A facile synthesis of (Z)-5-(substituted)-2-(methylthio) thiazol-4 (5H)-one using microwave irradiation and conventional method. Tetrahedron Lett., 2014, 55(5), 1107-1110.
[http://dx.doi.org/10.1016/j.tetlet.2013.12.113]
[14]
Guajardo, N.; Mueller, C.R.; Schrebler, R.; Carlesi, C.; Dominguez de Maria, P. Deep eutectic solvents for organocatalysis, biotransformations, and multistep organocatalyst/enzyme combinations. ChemCatChem, 2016, 8(6), 1020-1027.
[http://dx.doi.org/10.1002/cctc.201501133]
[15]
Yang, D-H.; Chen, Z-C.; Chen, S-Y.; Zheng, Q-G. Organic reactions in ionic liquids; ionic liquid-accelerated three-component reaction: a rapid one-potsynthesis of 3-alkyl-5-[(Z)-arylmethylidene]-1, 3-thiazolidine-2, 4-diones. Synthesis, 2003, 2003(12), 1891-1894.
[16]
Connon, S.J. Organocatalysis mediated by (thio)urea derivatives. Chemistry, 2006, 12(21), 5418-5427.
[http://dx.doi.org/10.1002/chem.200501076] [PMID: 16514689]
[17]
Omar, M.T.; Fouli, A-E.; El-Garhi, M.Z. Studies on 4-Thiazolidinones. IX, The Conversion of 5-Substituted 2-Thioxo-4-thiazolidinones into Corresponding 2, 4-Thiazolidinediones. Bull. Chem. Soc. Jpn., 1991, 64(2), 750-752.
[http://dx.doi.org/10.1246/bcsj.64.750]
[18]
Tomasić, T.; Zidar, N.; Šink, R.; Kovač, A.; Blanot, D.; Contreras-Martel, C.; Dessen, A.; Müller-Premru, M.; Zega, A.; Gobec, S.; Kikelj, D.; Masic, L.P. Structure-based design of a new series of D-glutamic acid based inhibitors of bacterial UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD). J. Med. Chem., 2011, 54(13), 4600-4610.
[http://dx.doi.org/10.1021/jm2002525] [PMID: 21591605]
[19]
Salaski, E.J.; Ayral-Kaloustian, S.; Epstein, J.W. 5-(Substituted)-5- (substitutedsulfonyl or sulfanyl) thiazolidine-2, 4-diones useful for inhibition of farnesyl-protein transferase. Google Patents 2004. WO/2003/018011
[20]
Zhang, J.; Zhang, Y.; Zhou, Z. Hydroxyl ammonium ionic liquid-catalyzed simple and efficient synthesis of 5-arylidene-2, 4-thiazolidinediones under solvent-free conditions. Green Chem. Lett. Rev., 2014, 7(1), 90-94.
[http://dx.doi.org/10.1080/17518253.2014.895866]
[21]
Khodair, A.I. A convenient synthesis of 2‐Arylidene‐5H‐thiazolo [2, 3‐b] quinazo‐line‐3, 5 [2H]‐diones and their benzoquinazoline derivatives. J. Heterocycl. Chem., 2002, 39(6), 1153-1160.
[http://dx.doi.org/10.1002/jhet.5570390607]
[22]
Veisi, H.; Vafajoo, Z.; Maleki, B.; Maghsoodlou, M.T. Facile and convenient synthesis of 5-Arylalkylidenerhodanines by Electrocatalytic crossed Aldol condensation. Phosphorus Sulfur Silicon Relat. Elem., 2013, 188(6), 672-677.
[http://dx.doi.org/10.1080/10426507.2012.717134]
[23]
Akhavan, M.; Foroughifar, N.; Pasdar, H.; Khajeh-Amiri, A.; Bekhradnia, A. Copper (II)-complex functionalized magnetite nanoparticles: a highly efficient heterogeneous nanocatalyst for the synthesis of 5-arylidenthiazolidine-2, 4-diones and 5-arylidene-2-thioxothiazolidin-4-one. Trans. Met. Chem., 2017, 42(6), 543-552.
[http://dx.doi.org/10.1007/s11243-017-0159-3]
[24]
Yanagisawa, H.; Takamura, M.; Yamada, E.; Fujita, S.; Fujiwara, T.; Yachi, M.; Isobe, A.; Hagisawa, Y. Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: synthesis and structure-activity relationship. Bioorg. Med. Chem. Lett., 2000, 10(4), 373-375.
[http://dx.doi.org/10.1016/S0960-894X(00)00003-2] [PMID: 10714503]
[25]
Chauhan, K.; Sharma, M.; Singh, P.; Kumar, V.; Shukla, P.K.; Siddiqi, M.I.; Chauhan, P.M. Discovery of a new class of dithiocarbamates and rhodanine scaffolds as potent antifungal agents: synthesis, biology and molecular docking. MedChemComm, 2012, 3(9), 1104-1110.
[http://dx.doi.org/10.1039/c2md20109g]
[26]
Liu, J.; Bolstad, D.B.; Smith, A.E.; Priestley, N.D.; Wright, D.L.; Anderson, A.C. Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors. Chem. Biol. Drug Des., 2009, 73(1), 62-74.
[http://dx.doi.org/10.1111/j.1747-0285.2008.00745.x] [PMID: 19152636]
[27]
Elshaier, Y.A.; Barakat, A.; Al-Qahtany, B.M.; Al-Majid, A.M.; Al-Agamy, M.H. Synthesis of pyrazole-thiobarbituric acid derivatives: antimicrobial activity and docking studies. Molecules, 2016, 21(10), 1337.
[http://dx.doi.org/10.3390/molecules21101337] [PMID: 27735850]
[28]
Bildirici, I.; Cetin, A.; Menges, N.; Alan, Y. Synthesis and SAR studies of pyrazole-3-carboxamides and-3-carbonyl thioureides including chiral moiety: novel candidates as antibacterial agents. J. Serb. Chem. Soc., 2018, 83(7-8), 795-807.
[http://dx.doi.org/10.2298/JSC170313029B]
[29]
Kaur, J.; Kaur, B.; Singh, P. Rational modification of semaxanib and sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase. Bioorg. Med. Chem. Lett., 2018, 28(2), 129-133.
[http://dx.doi.org/10.1016/j.bmcl.2017.11.049] [PMID: 29208523]
[30]
Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem., 2009, 30(16), 2785-2791.
[http://dx.doi.org/10.1002/jcc.21256] [PMID: 19399780]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 22
ISSUE: 10
Year: 2019
Page: [716 - 727]
Pages: 12
DOI: 10.2174/1386207322666191127103122
Price: $65

Article Metrics

PDF: 23
HTML: 5
EPUB: 1
PRC: 1